It was however a more recent study [61] involving CuII(atsm) treatment in a SOD1G37R mouse model of ALS that illustrated the potential link between copper-deficient SOD1 and ALS pathogenesis in vivo. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.